Qiagen, Maverix Expand Co-marketing Agreement | GenomeWeb

NEW YORK (GenomeWeb News) – Maverix Biomics said this week that it has extended an existing co-marketing agreement with Qiagen by integrating a second set of software products to support customers analyzing data from RNA-sequencing studies.

The partners have combined Qiagen's Ingenuity Pathway Analysis software with the Maverix Analytic platform to simplify the analysis and interpretation of RNA-seq data as well as speed up research, Maverix said. Last November, the companies integrated Qiagen Ingenuity iReport with the Maverix platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of 200 bird species, and more.

The Australian High Court rules that isolated genetic material cannot be patented.

The startup incubator Y Combinator is launching a nonprofit research lab.

In Genome Research this week: vervet genome, tandem repeats affect gene expression in great apes, and more.

Sponsored by
Oracle Health Sciences

Brian Wells of Penn Medicine will detail how his team's "PennOmics" integrated healthcare data warehouse accelerates clinical trial recruitment at the point of care, accepts data from wearables, and does it all in a secure, HIPAA- and research-compliant fashion.